Pharmaceutical & life sciences
Market entry. Launch readiness. Medical affairs. Market access. Start with the decision your existing evidence cannot answer.
I&E is engaging a small group of early partners to help shape high-value evidence engagements in Ghana. Bring a question, expertise or a shared ambition.
Healthcare investment and local manufacturing ambitions are increasing. Yet decision-grade local evidence remains difficult to assemble and use. I&E is being built to help close that gap.
Stronger evidence capability can improve how healthcare needs are understood, programmes are designed and resources are directed.
Market entry. Launch readiness. Medical affairs. Market access. Start with the decision your existing evidence cannot answer.
Understand local opportunity, patient pathways and adoption before scaling a product or service.
Explore responsible collaboration that strengthens research capacity and the usefulness of locally relevant evidence.
Bring clinical insight and research expertise to a principled conversation about evidence collaboration.
Explore strategic alignment around enabling responsible healthcare-evidence capability.
Scope the decision. Prioritize fit-for-purpose evidence.
Respect permissions, data minimisation and custodianship.
Scientific integrity, appropriate methods and transparent limitations.
Bring us the healthcare decision you are facing.
Let’s determine what evidence can answer it.